Target intelligence / Profile preview

Corneal surface hydration

Molecular classification
Other
01

Overview

Corneal surface hydration refers to the physiological state in which the cornea maintains an optimal level of water content necessary for transparency and proper vision. This is not a single molecular target but rather a complex process regulated by several mechanisms: • The tear film, particularly its lipid layer, prevents excessive evaporation from the ocular surface and helps maintain hydration[4]. • The corneal endothelium acts as an active barrier with ion pumps (notably Na+/K+-ATPase) that move fluid out of the stroma into the anterior chamber, counteracting water imbibition into the cornea[1][2]. Damage or loss of endothelial cells impairs this pump function, leading to stromal swelling (edema)[1]. • Tear evaporation contributes significantly to changes in corneal thickness; studies show that during recovery from swelling with eyes open, about 80% is due to osmotic thinning via tear evaporation while only 20% is due to endothelial pumping[2]. Disorders affecting these processes—such as dry eye disease (insufficient tear production/evaporation), endothelial dysfunction (Fuchs’ dystrophy), or exposure-related dehydration—can compromise vision by disrupting normal hydration balance. Because "corneal surface hydration" describes a physiological property rather than a discrete molecule/receptor/protein/gene, it should not be considered a canonical therapeutic target. Instead, therapies aim at modulating underlying mechanisms such as enhancing tear film stability or supporting endothelial cell function.

02

Mechanism of action

Enhancement or support of tear film stability to reduce evaporation[4] Stimulation or support of endothelial pump function to remove excess fluid from the stroma[2]

03

Biological functions

Maintenance of corneal transparencyRegulation of water content in the corneaProtection against edema
04

Disease associations

Corneal edemaDry eye diseaseOther corneal disorders
05

Safety considerations

Overuse of hyperosmotic agents may cause irritation or further dehydrationInsufficient hydration can lead to discomfort, visual disturbance, and increased risk for infection
06

Interacting drugs

Hyperosmotic agents (e.g., sodium chloride ophthalmic solutions)

1 more in the full profile.

07

Biomarkers

Corneal thickness (pachymetry)Endothelial cell density[1]

Beyond the preview

Go deeper on Corneal surface hydration.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Corneal surface hydration.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call